Expert Review of Vaccines
Volume 16, 2017 - Issue 6
Open access
1,197
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial
Shabir A Madhia Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa;c National Institute for Communicable Diseases: a division of National Health Laboratory Service, Johannesburg, South AfricaCorrespondence[email protected]
https://orcid.org/0000-0002-7629-0636View further author information
Anthonet Koena Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Lisa Josea Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Marta Moreirad GSK, Wavre, BelgiumView further author information
, Nadia van Niekerka Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Clare Cutlanda Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa;b Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South AfricaView further author information
, Nancy Françoisd GSK, Wavre, BelgiumView further author information
, Javier Ruiz-Guiñazúd GSK, Wavre, BelgiumView further author information
, Juan Pablo Yarzabald GSK, Wavre, BelgiumView further author information
, Dorota Borysd GSK, Wavre, BelgiumView further author information
& Lode Schuermand GSK, Wavre, BelgiumView further author information
show all
Pages 641-656
|
Received 22 Nov 2016, Accepted 19 Apr 2017, Published online: 15 May 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.